Table 1.

Prevalence of favorable and altered lipid profile in our cohort.

	Total group (n=69)	Without lipid lowering treatment (n=23)	With lipid lowering treatment (n=46)
Favorable lipid profile	8 (12%)	2 (9%)	6 (13%)
Dyslipidemia	61 (88%)	21 (91%)	40 (87%)
LDL-C greater than 100 mg/dL or greater than 70 mg/dL (in very high risk women**)	39 (58%)	16 (73%)	23 (51%)
HDL-C below 50 mg/dL	43 (62%)	14 (61%)	29 (63%)
Non-HDL-C greater than130 mg/dL or greater than 100 mg/dL (in very high risk women**)	39 (57%)	17 (74%)	22 (48%)
Triglycerides greater than 150 mg/dL	21 (30%)	4 (17%)	17 (37%)

^*A favorable lipid profile is defined as having: 1) LDL-C below 100 mg/dL or 70 mg/dL if very high risk, 2) HDL-C greater than 50 mg/dL, 3) non-HDL-C below 130 mg/dL or 100 mg/dL if very high risk, and 4) triglyceride level below 150 mg/dL [13, 14].

^**Criteria for very high risk include established cardiovascular disease (any indication of CAD, MI, Angina, PTCA, Coronary stent, CABG, CBVD, Stroke, TIA, Carotid stent, CEA, or Carotid surgery) plus diabetes and/or current smoking